Krishna Institute of Medical Sciences (KIMS.BO) Earnings Analysis

Krishna Institute of Medical Sciences (KIMS.BO) next reports earnings on 2026-08-12, consensus EPS 1.48 INR. Last quarter (2026-05-15) it missed with EPS 1.2 INR vs 1.53 INR est (-21.6%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E 129.75.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KIMS.BO next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate1.48 INR
Revenue estimate11.48B

KIMS.BO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-151.2 INR1.53 INR-21.6%Miss
2026-02-061.3 INR1.32 INR-1.5%Miss
2025-11-071.67 INR2.12 INR-21.2%Miss
2025-05-122.27 INR2.38 INR-4.6%Miss
2025-02-062.2 INR2.4 INR-8.3%Miss
2024-11-092.68 INR2.5 INR+7.2%Beat

Beat rate: 1/6 (17%) over reported quarters with consensus data.

KIMS.BO valuation and analyst view

Trailing P/E129.75
Trailing EPS6.021 INR
Price / book13.94
Dividend yield0.00%
Market cap314.90B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Krishna Institute of Medical Sciences (KIMS.BO)'s next earnings date?

Krishna Institute of Medical Sciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 1.48 INR and revenue estimate of 11.48B.

Did KIMS.BO beat earnings last quarter?

In its 2026-05-15 report, KIMS.BO posted EPS of 1.2 INR versus a 1.53 INR estimate — a miss of 21.6%.

What is KIMS.BO's earnings track record?

Over the last 6 reported quarters with consensus data, KIMS.BO beat estimates 1 times (17%).

What is KIMS.BO's current P/E ratio and EPS?

KIMS.BO trades at a trailing P/E of 129.75 on trailing EPS of 6.020805949972939 INR.

What do analysts rate KIMS.BO?

KIMS.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.